Oncoustics

Guardant Health is a U.S. precision oncology company that develops blood-based (liquid biopsy) tests that detect, monitor and guide treatment of cancer by analyzing circulating tumor DNA. Its products include Guardant360/Guardant360 CDx for advanced-cancer genomic profiling and companion diagnostics, Guardant Reveal for recurrence monitoring and Shield for blood-based colorectal cancer screening. It layers AI/machine-learning analytics (Guardant Galaxy, InfinityAI) on its proprietary multi-omic real-world dataset. Headquartered in Palo Alto, California; listed on Nasdaq (GH).

Founded in 2024 and based in San Francisco, Epsilon Health is an "AI-native" radiology practice that embeds purpose-built AI directly into board-certified radiologists' diagnostic workflows, accelerating interpretation while preserving physician oversight and care quality. It currently reads 2,500+ imaging studies per day, has served 250,000+ patients, and handles more than half the imaging volume of one of the largest U.S. outpatient imaging providers.

Founded in 2017 and based in Hangzhou, DeepInformatics++ combines AI with digital pathology, offering full-stack solutions for smart scanning, quality control and multi-cancer analysis, and developing the DeepPathAI foundation model. Its products cover 1,500+ hospitals nationwide with annual revenue growth above 100% since 2023.

Cleerly, founded in 2016 in New York, USA, develops AI-driven software that analyzes medical imaging to detect plaque buildup in cardiac arteries.

Craif, founded in 2018 in Tokyo, detects cancer at early stages using urine-based microRNA biomarkers and AI.

Evvy, founded in 2020 in New York by Priyanka Jain, Laine Bruzek and Pita Navarro, is a women's precision health company. Its core product is a CLIA/CLEP-certified at-home metagenomic (mNGS) vaginal microbiome test covering 700+ bacteria and fungi from a single swab, paired with clinician review, prescription treatment plans for bacterial vaginosis, yeast infections and aerobic vaginitis, one-to-one health coaching and a patient dashboard. It also offers EvvyAI, which applies machine learning to its proprietary sequencing dataset to generate personalized care pathways and surface novel biomarkers, and is expanding into fertility assessment.